ArticleRSC advances2025
Enhancing the antioxidant potential of a coumarin derivative
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Daphnetin is a naturally occurring coumarin. Despite its numerous positive biological effects, progress in its clinical trial use has been minimal due to its poor water solubility and limited oral bioavailability. This study focuses on the development of a novel and highly stable daphnetin-nickel complex (Ni-DAPH). We present a comprehensive investigation combining experimental and computational approaches to explore the synthesis, characterization, properties, reactivity, and biological activity of the Ni-DAPH complex. The computational studies, based on DFT, included geometry optimization HOMO and LUMO orbitals, UV-visible spectra, infrared (IR) and nuclear magnetic resonance (NMR) spectra, molecular electrostatic potential (MEP), non-covalent interaction (NCI) analysis, quantum theory of atoms in molecules (QTAIM), nonlinear optical (NLO) properties, and antioxidant activity. The molecular electrostatic potential (MEP) analysis identified nucleophilic and electrophilic sites within the complex, while the infrared spectra pinpointed the carbonyl group of the benzopyrone ring as the primary site of complexation. NMR spectroscopy revealed significant proton involvement in charge transfer between the ligand and the nickel center. Natural bond orbital (NBO) analysis indicated nearly equivalent bond angles, suggesting a symmetric geometry. QTAIM analysis confirmed the presence of ionic bonding with a partial covalent character, enhancing the stability of the complex. The ordering of the nickel 3d orbitals is characteristic of a distorted square-planar geometry. The hydrogen atom transfer (HAT) mechanism demonstrated that the Ni-DAPH complex exhibits significantly enhanced antioxidant activity in comparison to the free daphnetin ligand. This result was confirmed by molecular docking with the cytochrome C peroxidase (CCP) and ascorbate peroxidase (APX) HEME-enzymes, using the 2X08 and 1OAF receptor structures. The
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.